Reichert M - Search Results

1

Penetration of Isavuconazole in Ascites Fluid of Critically Ill Patients.

Lahmer T, Batres Baires G, Schmid RM, Wiessner JR, Ulrich J, Reichert M, Huber W, Sörgel F, Kinzig M, Rasch S, Mayr U. Lahmer T, et al. Among authors: reichert m. J Fungi (Basel). 2021 May 11;7(5):376. doi: 10.3390/jof7050376. J Fungi (Basel). 2021. PMID: 34064945 Free PMC article.

2

Phosphoinositide-3-kinase signaling controls S-phase kinase-associated protein 2 transcription via E2F1 in pancreatic ductal adenocarcinoma cells.

Reichert M, Saur D, Hamacher R, Schmid RM, Schneider G. Reichert M, et al. Cancer Res. 2007 May 1;67(9):4149-56. doi: 10.1158/0008-5472.CAN-06-4484. Cancer Res. 2007. PMID: 17483325

3

HMGA1 controls transcription of insulin receptor to regulate cyclin D1 translation in pancreatic cancer cells.

Kolb S, Fritsch R, Saur D, Reichert M, Schmid RM, Schneider G. Kolb S, et al. Among authors: reichert m. Cancer Res. 2007 May 15;67(10):4679-86. doi: 10.1158/0008-5472.CAN-06-3308. Cancer Res. 2007. PMID: 17510394

4

Casein kinase II inhibition induces apoptosis in pancreatic cancer cells.

Hamacher R, Saur D, Fritsch R, Reichert M, Schmid RM, Schneider G. Hamacher R, et al. Among authors: reichert m. Oncol Rep. 2007 Sep;18(3):695-701. Oncol Rep. 2007. PMID: 17671722

5

PI3K signaling maintains c-myc expression to regulate transcription of E2F1 in pancreatic cancer cells.

Schild C, Wirth M, Reichert M, Schmid RM, Saur D, Schneider G. Schild C, et al. Among authors: reichert m. Mol Carcinog. 2009 Dec;48(12):1149-58. doi: 10.1002/mc.20569. Mol Carcinog. 2009. PMID: 19603422

6

Mdm2 inhibitors synergize with topoisomerase II inhibitors to induce p53-independent pancreatic cancer cell death.

Conradt L, Henrich A, Wirth M, Reichert M, Lesina M, Algül H, Schmid RM, Krämer OH, Saur D, Schneider G. Conradt L, et al. Among authors: reichert m. Int J Cancer. 2013 May 15;132(10):2248-57. doi: 10.1002/ijc.27916. Epub 2012 Nov 26. Int J Cancer. 2013. PMID: 23115126

7

Efemp1 and p27(Kip1) modulate responsiveness of pancreatic cancer cells towards a dual PI3K/mTOR inhibitor in preclinical models.

Diersch S, Wenzel P, Szameitat M, Eser P, Paul MC, Seidler B, Eser S, Messer M, Reichert M, Pagel P, Esposito I, Schmid RM, Saur D, Schneider G. Diersch S, et al. Among authors: reichert m. Oncotarget. 2013 Feb;4(2):277-88. doi: 10.18632/oncotarget.859. Oncotarget. 2013. PMID: 23470560 Free PMC article.

8

Detection of Tumor Suppressor Genes in Cancer Development by a Novel shRNA-Based Method.

von Burstin J, Diersch S, Schneider G, Reichert M, Rustgi AK, Schmid RM. von Burstin J, et al. Among authors: reichert m. Mol Cancer Res. 2015 May;13(5):863-9. doi: 10.1158/1541-7786.MCR-14-0709. Epub 2015 Feb 27. Mol Cancer Res. 2015. PMID: 25724428 Free PMC article.

9

Membranous CD24 drives the epithelial phenotype of pancreatic cancer.

Lubeseder-Martellato C, Hidalgo-Sastre A, Hartmann C, Alexandrow K, Kamyabi-Moghaddam Z, Sipos B, Wirth M, Neff F, Reichert M, Heid I, Schneider G, Braren R, Schmid RM, Siveke JT. Lubeseder-Martellato C, et al. Among authors: reichert m. Oncotarget. 2016 Aug 2;7(31):49156-49168. doi: 10.18632/oncotarget.9402. Oncotarget. 2016. PMID: 27203385 Free PMC article.

10

MTOR inhibitor-based combination therapies for pancreatic cancer.

Hassan Z, Schneeweis C, Wirth M, Veltkamp C, Dantes Z, Feuerecker B, Ceyhan GO, Knauer SK, Weichert W, Schmid RM, Stauber R, Arlt A, Krämer OH, Rad R, Reichert M, Saur D, Schneider G. Hassan Z, et al. Among authors: reichert m. Br J Cancer. 2018 Feb 6;118(3):366-377. doi: 10.1038/bjc.2017.421. Epub 2018 Jan 2. Br J Cancer. 2018. PMID: 29384525 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

671 results

Search Page

Filters